Kymera Therapeutics, based in Cambridge, is at the forefront of advancing targeted protein degradation to develop next-generation medicines.
The company's innovative approach focuses on harnessing the power of protein degradation to create novel treatments for various diseases, promising a new era in medicine.
Generated from their website's infomation